A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
Clinical trial NCT01723904 · COMPLETED
Trial details
- NCT number
- NCT01723904
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.